Inhibrx Biosciences (INBX) Assets (2023 - 2025)
Inhibrx Biosciences (INBX) reported Assets of $146.5 million for Q4 2025, down 18.97% year-over-year from $180.8 million in Q4 2024, and down 17.46% quarter-over-quarter from $177.5 million in Q3 2025.
Inhibrx Biosciences (INBX) Assets (2023 - 2025) Analysis & Trends
Inhibrx Biosciences (INBX) has 3 years of Assets data on file, last reported at $146.5 million in Q4 2025.
- Assets for Q4 2025 came in at $146.5 million, down 18.97% year-over-year; the trailing twelve-month figure through Dec 2025 was $146.5 million (down 18.97% YoY), and the FY2025 annual result was $146.5 million, down 18.97% from the prior year.
- Assets declined to $146.5 million in Q4 2025 per INBX's latest filing, from $177.5 million in the prior quarter.
- Over five years, Assets peaked at $307.9 million in Q4 2023 and troughed at $146.5 million in Q4 2025.
- A 3-year average of $218.5 million and a median of $217.3 million in 2024 frame the typical range for Assets.
- The sharpest annual moves came in 2024 and 2025: Assets plunged 41.29% in 2024, then retreated 17.92% in 2025.
- A 3-year view of Assets shows it stood at $307.9 million in 2023, then slumped by 41.29% to $180.8 million in 2024, then fell by 18.97% to $146.5 million in 2025.
- Business Quant data shows INBX's Assets at $146.5 million in Q4 2025, $177.5 million in Q3 2025, and $212.1 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 37.37 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 811.27 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 14.93 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.73 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 23.64 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 33.89 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 12.81 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 26.48 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 640.56 Mn |
| 10 | Inhibrx Biosciences | 186.16 Mn | 186.16 Mn | - | 146.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 146.48 Mn |
| Sep 30, 2025 | 177.47 Mn |
| Jun 30, 2025 | 212.12 Mn |
| Mar 31, 2025 | 242.64 Mn |
| Dec 31, 2024 | 180.77 Mn |
| Sep 30, 2024 | 222.56 Mn |
| Jun 30, 2024 | 258.42 Mn |
| Dec 31, 2023 | 307.89 Mn |